DA
ZLAB icon

DCF Advisers’s Zai Lab ZLAB Stock Holding History

DCF Advisers’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,500
Closed -$26.5K – 107
2025
Q4 		$26.5K Buy
+1,500
New +$35.1K 0.01% 95

Other funds holding ZLAB

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

DCF Advisers's ZLAB Position: Q1 2026 in Review

DCF Advisers reduced its Zai Lab (ZLAB) stake by 35% in Q1 2026, selling an estimated $630K and leaving 63,500 shares worth $1.19M. The position accounts for 0.32% of the portfolio, ranked #52.

DCF Advisers first reported a position in ZLAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.25M in Q1 2025. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • DCF Advisers held 63,500 shares of Zai Lab worth $1.19M as of Q1 2026.
  • DCF Advisers sold 34,000 Zai Lab shares in Q1 2026, an estimated $630K.
  • Zai Lab made up 0.32% of DCF Advisers's portfolio in Q1 2026, its #52 holding.
  • DCF Advisers first reported a position in Zai Lab in Q2 2024 and has held it in 8 quarters since.
  • DCF Advisers's Zai Lab position peaked at $3.25M in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.